139 related articles for article (PubMed ID: 20650264)
21. Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.
Zha L; Cao Q; Cui X; Li F; Liang H; Xue B; Shi H
Med Oncol; 2016 Mar; 33(3):21. PubMed ID: 26819089
[TBL] [Abstract][Full Text] [Related]
22. UTX demethylase activity is required for satellite cell-mediated muscle regeneration.
Faralli H; Wang C; Nakka K; Benyoucef A; Sebastian S; Zhuang L; Chu A; Palii CG; Liu C; Camellato B; Brand M; Ge K; Dilworth FJ
J Clin Invest; 2016 Apr; 126(4):1555-65. PubMed ID: 26999603
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
Rath BH; Waung I; Camphausen K; Tofilon PJ
Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
[TBL] [Abstract][Full Text] [Related]
24. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
25. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
26. Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit.
Blais A; van Oevelen CJ; Margueron R; Acosta-Alvear D; Dynlacht BD
J Cell Biol; 2007 Dec; 179(7):1399-412. PubMed ID: 18166651
[TBL] [Abstract][Full Text] [Related]
27. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth.
Smith EJ; Leone G; Nevins JR
Cell Growth Differ; 1998 Apr; 9(4):297-303. PubMed ID: 9563849
[TBL] [Abstract][Full Text] [Related]
28. The retinoblastoma tumour suppressor in development and cancer.
Classon M; Harlow E
Nat Rev Cancer; 2002 Dec; 2(12):910-7. PubMed ID: 12459729
[TBL] [Abstract][Full Text] [Related]
29. Differences in stability of repressor complexes at promoters underlie distinct roles for Rb family members.
Young AP; Longmore GD
Oncogene; 2004 Jan; 23(3):814-23. PubMed ID: 14737116
[TBL] [Abstract][Full Text] [Related]
30. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways.
Alessio N; Squillaro T; Cipollaro M; Bagella L; Giordano A; Galderisi U
Oncogene; 2010 Oct; 29(40):5452-63. PubMed ID: 20697355
[TBL] [Abstract][Full Text] [Related]
31. UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1.
Choi HJ; Park JH; Park M; Won HY; Joo HS; Lee CH; Lee JY; Kong G
EMBO Rep; 2015 Oct; 16(10):1288-98. PubMed ID: 26303947
[TBL] [Abstract][Full Text] [Related]
32. The H3K27me3 demethylase UTX in normal development and disease.
Van der Meulen J; Speleman F; Van Vlierberghe P
Epigenetics; 2014 May; 9(5):658-68. PubMed ID: 24561908
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
[TBL] [Abstract][Full Text] [Related]
34. Histone Demethylase Activity of Utx Is Essential for Viability and Regulation of
Copur Ö; Müller J
Genetics; 2018 Feb; 208(2):633-637. PubMed ID: 29247011
[TBL] [Abstract][Full Text] [Related]
35. The histone demethylase UTX enables RB-dependent cell fate control.
Wang JK; Tsai MC; Poulin G; Adler AS; Chen S; Liu H; Shi Y; Chang HY
Genes Dev; 2010 Feb; 24(4):327-32. PubMed ID: 20123895
[TBL] [Abstract][Full Text] [Related]
36. Role of UTX in retinoic acid receptor-mediated gene regulation in leukemia.
Rocha-Viegas L; Villa R; Gutierrez A; Iriondo O; Shiekhattar R; Di Croce L
Mol Cell Biol; 2014 Oct; 34(19):3765-75. PubMed ID: 25071154
[TBL] [Abstract][Full Text] [Related]
37. DISORDERED HISTONE METHYLATION IN HEMATOLOGICAL MALIGNANCIES THE CASE OF UTX/KDM6A.
Licht JD
Trans Am Clin Climatol Assoc; 2018; 129():24-36. PubMed ID: 30166694
[TBL] [Abstract][Full Text] [Related]
38. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
[TBL] [Abstract][Full Text] [Related]
39. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-4-mediated 15-lipoxygenase-1 trans-activation requires UTX recruitment and H3K27me3 demethylation at the promoter in A549 cells.
Han H; Xu D; Liu C; Claesson HE; Björkholm M; Sjöberg J
PLoS One; 2014; 9(1):e85085. PubMed ID: 24465480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]